BusinessAxsome Therapeutics to Present at Upcoming Investor ConferencesBy Nasdaq OMXSep 18, 2017, 11:00 AM UTC
BusinessBioCryst Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Completion of Public Offering of Common StockBy Nasdaq OMXSep 15, 2017, 4:00 PM UTC
BusinessMyriad Genetics Announces Positive Data Supporting New riskScore™ Test at the 36th Annual Conference of the National Society of Genetic CounselorsBy Nasdaq OMXSep 15, 2017, 11:05 AM UTC
BusinessAdvanced Medical Isotope Corporation (ADMD) has its first discussions with private animal consortiums to utilize RadioGelT™By Nasdaq OMXSep 14, 2017, 11:22 AM UTC
BusinessMARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTOBy Nasdaq OMXSep 14, 2017, 11:00 AM UTC
BusinessCrownBio’s Integrated Oncology Platform Helps Advance Apogenix’s Promising HERA-GITRL Immunotherapy for NSCLC and Head and Neck CancerBy Nasdaq OMXSep 13, 2017, 2:04 PM UTC
BusinessRedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S.By Nasdaq OMXSep 13, 2017, 11:00 AM UTC
BusinessAmarin Appoints Mark W. Salyer to New Position of Chief Commercial OfficerBy Nasdaq OMXSep 13, 2017, 10:00 AM UTC